Noble Corp's first-quarter report reveals substantial contract additions, financial growth, and a positive market outlook, driving a significant increase in the company's stock value and investor confidence.
Water management company Northwest Pipe (NASDAQ:NWPX) beat Wall Street’s revenue expectations in Q1 CY2025, with sales up 2.6% year on year to $116.1 million. Its GAAP profit of $0.39 per share was 26.9% below analysts’ consensus estimates.
Diabetes technology company Tandem Diabetes Care (NASDAQ:TNDM) beat Wall Street’s revenue expectations in Q1 CY2025, with sales up 22.3% year on year to $234.4 million. The company expects the full year’s revenue to be around $1 billion, close to analysts’ estimates. Its GAAP loss of $1.97 per share was significantly below analysts’ consensus estimates.
Diversified solutions provider Matthews International (NASDAQ:MATW) fell short of the market’s revenue expectations in Q1 CY2025, with sales falling 9.3% year on year to $427.6 million. Its non-GAAP profit of $0.34 per share was 10.5% below analysts’ consensus estimates.
Bedding manufacturer and retailer Sleep Number (NASDAQ:SNBR) fell short of the market’s revenue expectations in Q1 CY2025, with sales falling 16.4% year on year to $393.3 million. Its GAAP loss of $0.38 per share was significantly below analysts’ consensus estimates.
Online casino and sports betting company Rush Street Interactive (NYSE:RSI) reported Q1 CY2025 results exceeding the market’s revenue expectations, with sales up 20.7% year on year to $262.4 million. On the other hand, the company’s full-year revenue guidance of $1.05 billion at the midpoint came in 0.8% below analysts’ estimates. Its non-GAAP profit of $0.09 per share was 47.7% above analysts’ consensus estimates.
Medical tech company CONMED (NYSE:CNMD) reported Q1 CY2025 results beating Wall Street’s revenue expectations, with sales up 2.9% year on year to $321.3 million. The company expects the full year’s revenue to be around $1.36 billion, close to analysts’ estimates. Its non-GAAP profit of $0.95 per share was 17.1% above analysts’ consensus estimates.
Diabetes technology company Tandem Diabetes Care (NASDAQ:TNDM) reported revenue ahead of Wall Street’s expectations in Q1 CY2025, with sales up 22.3% year on year to $234.4 million. The company expects the full year’s revenue to be around $1 billion, close to analysts’ estimates. Its GAAP loss of $1.97 per share was significantly below analysts’ consensus estimates.
IT solutions provider Connection (NASDAQ:CNXN) reported Q1 CY2025 results topping the market’s revenue expectations, with sales up 10.9% year on year to $701 million. Its non-GAAP profit of $0.60 per share was 44.6% above analysts’ consensus estimates.
PCB manufacturing company TTM Technologies (NASDAQ:TTMI) reported Q1 CY2025 results beating Wall Street’s revenue expectations, with sales up 13.8% year on year to $648.7 million. On top of that, next quarter’s revenue guidance ($670 million at the midpoint) was surprisingly good and 4% above what analysts were expecting. Its non-GAAP profit of $0.50 per share was 26.6% above analysts’ consensus estimates.
